Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China flag China · Delayed Price · Currency is CNY
5.53
+0.14 (2.60%)
Apr 30, 2026, 3:04 PM CST

SHE:002793 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
798.45550.11456.68692.91,4342,002
Short-Term Investments
-----20.03
Trading Asset Securities
841.252.117.112.58
Cash & Short-Term Investments
806.45554.11457.936951,4512,034
Cash Growth
93.86%21.00%-34.11%-52.10%-28.68%57.99%
Accounts Receivable
339.83441.45601.57598.89996.33,255
Other Receivables
55.56171.88158.71217.411,26980.46
Receivables
395.38613.34760.28816.32,2663,336
Inventory
347.33323.62459.56455.61684.99709.08
Other Current Assets
206.46437.87106.62100.6320.34289.32
Total Current Assets
1,7561,9291,7842,0684,7226,368
Property, Plant & Equipment
730.86759.341,2961,6301,7772,071
Long-Term Investments
271.29202.91243.12245.06231.9665.24
Goodwill
1.951.951.951.954.389.76
Other Intangible Assets
385.86396.55487.37476.24392.81338.11
Long-Term Deferred Tax Assets
171.32184.91188.39286.15428.61183.67
Long-Term Deferred Charges
213.73210.65204.61244.17281.37371.45
Other Long-Term Assets
38.4840.03129.68166.77280.5989.14
Total Assets
3,5693,7254,3365,1178,1199,497
Accounts Payable
497.72499.42544.1384.89512.25899.77
Accrued Expenses
99.8244.45233.3255.18252.25479.23
Short-Term Debt
1,025876.93742.08555.62,4021,945
Current Portion of Long-Term Debt
158.142.1591.52405.65821.15275.53
Current Portion of Leases
-69.5870.763.7365.4412.81
Current Income Taxes Payable
140.791.011.7910.8361.81
Current Unearned Revenue
49.5553.3266.04134.28169.28152.12
Other Current Liabilities
463.64551.47289.23116.43141.13181.1
Total Current Liabilities
2,3082,2982,5381,9184,3754,007
Long-Term Debt
-92133.38429.23190.93567.13
Long-Term Leases
8.9157.2102.6466.09142.0257.13
Long-Term Unearned Revenue
21.2222.2878.9289.9393.58102.22
Long-Term Deferred Tax Liabilities
--7.367.5810.29-
Other Long-Term Liabilities
55.9420.0716.2934.6-27.28
Total Liabilities
2,3942,4902,8772,5454,8124,761
Common Stock
1,0881,0881,0881,0881,0881,464
Additional Paid-In Capital
310.21397.04380.18472.99514.77175.4
Retained Earnings
-341.87-366.02-77.44888.051,5492,789
Treasury Stock
---30---40.66
Comprehensive Income & Other
43.8845.4321.9521.2723.33-2.74
Total Common Equity
1,1001,1641,3822,4703,1754,385
Minority Interest
75.3971.6677.13102.51132.37351.2
Shareholders' Equity
1,1751,2361,4592,5723,3074,736
Total Liabilities & Equity
3,5693,7254,3365,1178,1199,497
Total Debt
1,1921,0981,6401,5203,6222,858
Net Cash (Debt)
-385.61-543.68-1,182-825.31-2,171-823.17
Net Cash Per Share
-0.36-0.51-1.11-0.76-1.52-0.57
Filing Date Shares Outstanding
1,0691,0881,0611,0881,0881,464
Total Common Shares Outstanding
1,0691,0881,0611,0881,0881,464
Working Capital
-552.24-369.11-753.6149.96347.072,361
Book Value Per Share
1.031.071.302.272.923.00
Tangible Book Value
711.99765.53892.961,9922,7784,037
Tangible Book Value Per Share
0.670.700.841.832.552.76
Buildings
-872.381,1191,0711,0681,227
Machinery
-1,1561,3651,3211,3761,376
Construction In Progress
-6.320.43336.86294.22362.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.